Phase 1 Evaluation of Triple Therapy with Boserolimab (Anti-Cd27 Agonist), Pembrolizumab, and Chemotherapy in Patients with Triple-Negative Breast Cancer (TNBC) with PD-L1 Combined Positive Score (CPS) <10: Safety, Antitumor Activity, and Association Between Biomarkers and Response

Carlos Rojas, Bernard Gaston Doger de Speville, Seock-Ah Im, Ronnie Shapira-Frommer, Maria De Miguel, Lucia Gonzalez Cortijo,Margarita Romeo Marin, Maja de Jonge, Mark Ayers,Yiwei Zhang, Song Zhai,Elliot Chartash, Konstantin Dobrenkov, Joohyuk Sohn

CANCER RESEARCH（2024）

引用 0|浏览0

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要